Literature DB >> 6196566

Contribution of noradrenergic and serotonergic neurons to the circulatory effects of centrally acting clonidine and alpha-methyldopa in rabbits.

G A Head, P I Korner, S L Lewis, E Badoer.   

Abstract

The effects of intracisternal clonidine (0.04, 0.2, and 1.0 microgram/kg) and of alpha-methyldopa (alpha-MD; 400 micrograms/kg) on mean arterial pressure (MAP) and heart rate (HR) were studied in conscious rabbits before, and 7 and 14 days after, intracisternal injection of (a) vehicle, (b) 6-hydroxydopamine (6-OHDA; 600 micrograms/kg), or (c) 5,6-dihydroxytryptamine (5,6-DHT; 633 micrograms/kg) (n = 6 per group). In the initial control experiment clonidine and alpha-MD produced similar falls in MAP and HR in each group; there was also good reproducibility of responses in vehicle-treated rabbits on the 3 experimental days. But after 6-OHDA or 5,6-DHT administration the circulatory effects of clonidine and alpha-MD were markedly attenuated. On day 14 after injection of 6-OHDA, the clonidine-induced falls in MAP and HR averaged 38 and 18%, respectively, of the control responses (p less than 0.001). On day 14 after 5,6-DHT administration, the falls in MAP and HR after clonidine administration were reduced to 27 and 13% of control, respectively (p less than 0.01), while the corresponding responses after alpha-MD administration were 39 and 61% of control (p less than 0.05). Neurochemical findings suggest that 6-OHDA affected noradrenergic (NA), dopaminergic (DA), but not serotonergic (5HT) neurons, and that 5,6-DHT affected 5HT but not NA and DA neurons. We conclude that the circulatory effects of clonidine and alpha-MD are mediated through both central NA and 5HT neurons.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196566     DOI: 10.1097/00005344-198311000-00006

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  12 in total

1.  Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution.

Authors:  C N May; M R Dashwood; C J Whitehead; C J Mathias
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

Review 2.  The role of 5-hydroxytryptamine and 5-hydroxytryptaminergic mechanisms in hypertension.

Authors:  P A van Zwieten; G J Blauw; P van Brummelen
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

Review 3.  Central serotonergic mechanisms in cardiovascular regulation.

Authors:  J Minson; J Chalmers; G Drolet; V Kapoor; I Llewellyn-Smith; E Mills; M Morris; P Pilowsky
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

4.  Intracisternal naloxone and cardiac nerve blockade prevent vasodilatation during simulated haemorrhage in awake rabbits.

Authors:  R G Evans; J Ludbrook; S J Potocnik
Journal:  J Physiol       Date:  1989-02       Impact factor: 5.182

Review 5.  The role of serotonin in cardiovascular diseases and their treatment.

Authors:  P A van Zwieten; G J Blauw; P van Brummelen
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

6.  Investigation of the central sites at which morphine acts to cause hypertension in conscious rabbits.

Authors:  C N May; C J Whitehead; M R Dashwood; C J Mathias
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

7.  Effect of bombesin on thermoregulation of the rabbit.

Authors:  L Janský; W Riedel; E Simon; C Simon-Oppermann; S Vybíral
Journal:  Pflugers Arch       Date:  1987-07       Impact factor: 3.657

Review 8.  Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha-adrenoceptor activity.

Authors:  P A van Zwieten; G J Blauw; P van Brummelen
Journal:  Drugs       Date:  1990       Impact factor: 9.546

9.  The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects.

Authors:  A D Struthers; M J Brown; E F Adams; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

10.  Cardiovascular effects of agmatine, a "clonidine-displacing substance", in conscious rabbits.

Authors:  B Szabo; R Urban; N Limberger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.